Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Elliyeh Ghadrdan"'
Autor:
Amirhosein Ghahremanian, Hasti Photography, Sona Ghasemi, Mohammadreza Heidari, Elliyeh ghadrdan
Publikováno v:
Journal of Pharmaceutical Care, Vol 11, Iss 3 (2023)
Background: One of the FDA-approved treatments for COVID-19 is remdesivir. In this study, we investigated adverse drug events (ADEs) of remdesivir in COVID-19 patients who contacted 13-Aban pharmacy's drug and poison information center (DPIC). Method
Externí odkaz:
https://doaj.org/article/9700caf8851f47e1bef6d716734e7b6d
Publikováno v:
Journal of Pharmaceutical Care, Vol 10, Iss 1 (2022)
Abstract Backgrounds: The pharmacists have a crucial role in providing pharmaceutical care to patients who receive anticoagulants. This study was conducted to evaluate the pharmacists’ confidence in pharmaceutical consultation in the field of an
Externí odkaz:
https://doaj.org/article/db48ed8fa3de4a65aaa1a2d8b8f1362c
Publikováno v:
Journal of Pharmaceutical Care, Vol 8, Iss 3 (2020)
Prolactin is a polypeptide hormone secreted and released by lactotroph cells in the anterior pituitary gland in response to diverse physiological stimuli, principally via the inhibitory action of dopamine and serotonin. This paper describes a 44-year
Externí odkaz:
https://doaj.org/article/5767bf36083b4cdea748b43325bfc3d3
Publikováno v:
Journal of Pharmaceutical Care, Vol 6, Iss 3-4 (2019)
Background: Patients’ knowledge, attitude, and practice are essential factors for hypertension management. Therefore, the information that reflects the level of public awareness can affect health policies. The aim of this study is to assess the kno
Externí odkaz:
https://doaj.org/article/acb0c655c61143cb8c82c0d23356e5a6
Publikováno v:
Iranian Journal of Psychiatry, Vol 13, Iss 4 (2018)
Methylphenidate, a stimulant, is prescribed commonly in the treatment of attention deficit hyperactivity disorder (ADHD) in children and adults. Methylphenidate is generally considered a safe medication, however, some rare adverse effects, such as ps
Externí odkaz:
https://doaj.org/article/643a4c10ddd24131adf971848c28d573
Autor:
Elliyeh Ghadrdan
Publikováno v:
Open Access Journal of Biomedical Science. 4
Autor:
Elliyeh Ghadrdan, Samira Chaibakhsh, Sanambar Sadighi, Zahra Jahangard-Rafsanjani, Sholeh Ebrahimpour
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 26(7)
Introduction Cisplatin-associated acute kidney injury (AKI) is the major limitation to the use of cisplatin-based chemotherapy regimens. Serum creatinine as a traditional marker did not increase in a timely enough fashion in AKI patients. Therefore,